Jaguar Health (JAGX) Times Interest Earned (2014 - 2026)
Jaguar Health's (JAGX) quarterly Times Interest Earned came in at $5.9 in Q1 2026, up 134.23% year-on-year from $2.52 in Q1 2025, and up 101.44% on a QoQ basis from -$408.5 in Q4 2025.
Jaguar Health (JAGX) Times Interest Earned (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Times Interest Earned data on file, last reported at $5.9 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 134.23% year-over-year to $5.9 in Q1 2026; TTM through Mar 2026 was -$15.23, a 73.99% increase from a year earlier, with the FY2025 full-year figure at -$25.18, down 7542.52% from the prior year.
- Times Interest Earned for Q1 2026 stood at $5.9, up from -$408.5 in the prior quarter.
- Over the last five years, Times Interest Earned for JAGX reached as high as $74.15 in Q4 2024 and fell as low as -$408.5 in Q4 2025.
- Historically, Times Interest Earned has averaged -$22.65 across 5 years, with a median of -$3.62 in 2022.
- Across the five-year window, Times Interest Earned jumped 6068.08% in 2024 and slumped 1064.63% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$0.49 in 2022, then plunged by 151.15% to -$1.24 in 2023, then soared by 6068.08% to $74.15 in 2024, then plunged by 650.88% to -$408.5 in 2025, then soared by 101.44% to $5.9 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were $5.9 in Q1 2026, -$408.5 in Q4 2025, and -$3.97 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | -157.58 |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 7.60 |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 2.71 |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | 22.72 |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | -2.48 |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 3.88 |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | -0.38 |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 5.90 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.90 |
| Dec 31, 2025 | -408.50 |
| Sep 30, 2025 | -3.97 |
| Jun 30, 2025 | -3.84 |
| Mar 31, 2025 | -17.22 |
| Dec 31, 2024 | 74.15 |
| Sep 30, 2024 | -4.04 |
| Jun 30, 2024 | -3.90 |
| Mar 31, 2024 | -1.48 |
| Dec 31, 2023 | -1.24 |
| Sep 30, 2023 | -4.50 |
| Jun 30, 2023 | -2.35 |
| Mar 31, 2023 | -4.51 |
| Dec 31, 2022 | -0.49 |
| Sep 30, 2022 | -3.62 |
| Jun 30, 2022 | -2.55 |
| Mar 31, 2022 | -2.80 |
| Dec 31, 2021 | 3.50 |
| Sep 30, 2021 | -4.59 |
| Jun 30, 2021 | -5.76 |